Consolidated Financial Statements for the Third Quarter Ended December 31, 2017

On January 30, 2018 Consolidated Financial Statements for the Third Quarter Ended December 31, 2017 (Presentation, Takara Bio, JAN 30, 2018, View Source [SID1234524044]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!